Skip to main content

Closed

CODX: Co-Diagnostics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-84.1% / yr

Operating margin-4447.4%

ROIC-171.0%

Financially safe

Stretched

Debt / equity0.13×

Interest coverage0.0×

Current ratio2.28×

Co-Diagnostics, Inc.

CODXNASDAQ·USD·Closed

Co-Diagnostics, Inc.

CODXNASDAQ·USD·Closed

$1.44

−7.69%

$1.44

−$0.12 (7.69%)

52W Range

0thpctl

Volume

0.06×avg

Mkt Cap

1.61MUSD

P/E

-0.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.06×avg

Market Cap

1.61MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings